Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts.

about

Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts.

Item

http://www.wikidata.org/entity/Q36379148

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Dose intense, dose dense and t ...... cer: an evolution of concepts.

@ast

Dose intense, dose dense and t ...... cer: an evolution of concepts.

@en

type

Item

label

Dose intense, dose dense and t ...... cer: an evolution of concepts.

@ast

Dose intense, dose dense and t ...... cer: an evolution of concepts.

@en

prefLabel

Dose intense, dose dense and t ...... cer: an evolution of concepts.

@ast

Dose intense, dose dense and t ...... cer: an evolution of concepts.

@en

P1476

Dose intense, dose dense and t ...... cer: an evolution of concepts.

@en

P2093

Alexios Matikas

http://www.w3.org/2001/XMLSchema#string

Jonas Bergh

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients

Clinical applications of palifermin: amelioration of oral mucositis and other potential indications

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Supervised risk predictor of breast cancer based on intrinsic subtypes

German Adjuvant Intergroup Node-positive Study (GAIN): A Phase III Trial Comparing Two Dose-Dense Regimens (iddEPC vs. ddEC-PwX) in High-Risk Early Breast Cancer Patients.

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.

Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial.

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.

P304

1143-1151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1329593

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Theodoros Foukakis

P577

2017-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28537808

http://www.w3.org/2001/XMLSchema#string